ES469020A1 - Procedimiento para la preparacion de nuevos 1-acil-2-hidroxi-1,3-diaminopropanos - Google Patents

Procedimiento para la preparacion de nuevos 1-acil-2-hidroxi-1,3-diaminopropanos

Info

Publication number
ES469020A1
ES469020A1 ES469020A ES469020A ES469020A1 ES 469020 A1 ES469020 A1 ES 469020A1 ES 469020 A ES469020 A ES 469020A ES 469020 A ES469020 A ES 469020A ES 469020 A1 ES469020 A1 ES 469020A1
Authority
ES
Spain
Prior art keywords
acyl
pharmaceutical compositions
diaminopropan
ols
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES469020A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Products GmbH
Original Assignee
Kali Chemie Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19772720968 external-priority patent/DE2720968C2/de
Priority claimed from DE2720915A external-priority patent/DE2720915C2/de
Application filed by Kali Chemie Pharma GmbH filed Critical Kali Chemie Pharma GmbH
Publication of ES469020A1 publication Critical patent/ES469020A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/36—Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
ES469020A 1977-05-10 1978-04-21 Procedimiento para la preparacion de nuevos 1-acil-2-hidroxi-1,3-diaminopropanos Expired ES469020A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19772720968 DE2720968C2 (de) 1977-05-10 1977-05-10 N↓1↓-Acyl-2-hydroxy-1,3-diaminopropane und Arzneimittel
DE2720915A DE2720915C2 (de) 1977-05-10 1977-05-10 N↓1↓-Acyl-2-hydroxy-1,3-diaminopropane und Arzneimittel mit diesen Verbindungen als Wirkstoff

Publications (1)

Publication Number Publication Date
ES469020A1 true ES469020A1 (es) 1979-09-01

Family

ID=25771998

Family Applications (1)

Application Number Title Priority Date Filing Date
ES469020A Expired ES469020A1 (es) 1977-05-10 1978-04-21 Procedimiento para la preparacion de nuevos 1-acil-2-hidroxi-1,3-diaminopropanos

Country Status (18)

Country Link
US (2) US4191770A (en, 2012)
JP (1) JPS53141224A (en, 2012)
AT (1) AT357144B (en, 2012)
AU (1) AU520625B2 (en, 2012)
CH (1) CH636845A5 (en, 2012)
DD (1) DD135195A5 (en, 2012)
DK (1) DK201878A (en, 2012)
ES (1) ES469020A1 (en, 2012)
FR (1) FR2390422A1 (en, 2012)
GB (1) GB1585758A (en, 2012)
IE (1) IE46778B1 (en, 2012)
IL (1) IL54677A (en, 2012)
IT (1) IT1098213B (en, 2012)
NL (1) NL7805038A (en, 2012)
NO (1) NO147749C (en, 2012)
NZ (1) NZ187221A (en, 2012)
PH (1) PH14558A (en, 2012)
SU (1) SU906365A3 (en, 2012)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2459235A1 (fr) * 1979-06-14 1981-01-09 Sanofi Sa Nouveaux derives de sulfonyl-aniline, leur procede de preparation et leur application therapeutique
JPS58177953A (ja) * 1982-04-13 1983-10-18 Eisai Co Ltd ポリプレニルカルボン酸アミドおよびその製造方法
US4596813A (en) * 1982-11-04 1986-06-24 Chevron Research Company Pyridylcarbonyl and thiocarbonyl derivatives useful as fungicides
AU6087194A (en) * 1993-01-15 1994-08-15 Agouron Pharmaceuticals, Inc. Hiv protease inhibitors
US5824821A (en) * 1997-02-07 1998-10-20 Nycomed Imaging As Process for the preparation of iodinated contrast agents and intermediates therefor
HUP0004388A3 (en) * 1997-11-07 2001-10-29 Upjohn Co Process for the preparation of oxazolidinones, intermediates and preparation thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1805355A (en) * 1929-01-02 1931-05-12 Ig Farbenindustrie Ag Basic compounds and process of preparing them
US2658076A (en) * 1951-06-12 1953-11-03 Searle & Co N-dialkylaminoalkyl derivatives of alpha, beta-diarylalkanoamides and their salts
BE794424A (fr) * 1972-01-24 1973-07-23 Science Union & Cie Nouveaux dibenzocycloheptenes, leur procede d'obtention et leur application comme medicament
DE2265370C2 (de) * 1972-05-03 1982-12-02 Kali-Chemie Ag, 3000 Hannover 6-Phenyl-1,2,3,4-tetrahydro-1,5-benzodiazocinderivate
GB1374366A (en) * 1972-07-21 1974-11-20 Science Union & Cie Propanol derivatives and a process for their preparation
GB1436593A (en) * 1973-03-15 1976-05-19 Science Union & Cie N-substituted acetamides processes for their preparation and pharmaceutical compositions containing them apparatus for processing photograp
DE2314993A1 (de) * 1973-03-26 1974-10-03 Kali Chemie Pharma Gmbh Neue benzodiazepinderivate und verfahren zu deren herstellung
US4141987A (en) * 1974-06-05 1979-02-27 Imperial Chemical Industries Limited 1-Aryloxy-3-thenamidoalkylamino-2-propanol derivatives
DE2448259A1 (de) * 1974-10-10 1976-04-22 Kali Chemie Pharma Gmbh Verfahren zur herstellung von 2-halogenmethyl-1,4-benzodiazepinen
US4144343A (en) * 1978-01-04 1979-03-13 Merck & Co., Inc. Heterocycle substituted (3-loweralkylamino-2-R1 O-propoxy)pyridines

Also Published As

Publication number Publication date
NL7805038A (nl) 1978-11-14
JPS6252740B2 (en, 2012) 1987-11-06
DD135195A5 (de) 1979-04-18
IL54677A (en) 1981-02-27
IE46778B1 (en) 1983-09-21
SU906365A3 (ru) 1982-02-15
IT7823159A0 (it) 1978-05-09
IE780921L (en) 1978-11-10
JPS53141224A (en) 1978-12-08
DK201878A (da) 1979-02-14
FR2390422B1 (en, 2012) 1980-07-18
NZ187221A (en) 1980-12-19
NO147749B (no) 1983-02-28
FR2390422A1 (fr) 1978-12-08
CH636845A5 (de) 1983-06-30
NO781631L (no) 1978-11-13
AT357144B (de) 1980-06-25
US4402981A (en) 1983-09-06
AU3594178A (en) 1979-11-15
ATA335178A (de) 1979-11-15
AU520625B2 (en) 1982-02-11
IL54677A0 (en) 1978-07-31
GB1585758A (en) 1981-03-11
IT1098213B (it) 1985-09-07
US4191770A (en) 1980-03-04
PH14558A (en) 1981-09-24
NO147749C (no) 1983-06-08

Similar Documents

Publication Publication Date Title
MY107341A (en) Novel hydroxamic acid and n-hydroxyurea derivatives and their use
CA2030433A1 (en) New isoquinoline- carboxamide amino acid derivatives useful for treatment of viral diseases
ZA9711607B (en) Novel cyclosporin derivatives, their preparation and the pharmaceutical compositions which contain them.
ES8603870A1 (es) Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol.
PT74703B (en) Process for the preparation of pharmaceutical compositions for topical use which are penetrable through the skin and contain as an active ingredient amongst others (e)-n-methyl-6,6-dimethyl-n-(naphtylmethyl)-hept-2-en-4-inyl-1-amine
ZA9711606B (en) Cyclosporin derivatives, their preparation and the pharmaceutical compositions which contain them.
ES479474A1 (es) Procedimiento para la obtencion de una composicion a base dederivados de la piridina de accion cerebral.
EP0279149A3 (en) Benzimidazole derivatives, process for their production and a pharmaceutical composition containing the same
ES475035A1 (es) Un procedimiento para preparar derivados del acido cefalosporanico.
MX9307509A (es) Metodo y preparacion farmaceutica para reducir la actividad de las celulas.
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
IE43693L (en) Androstane derivatives
TNSN90021A1 (fr) Procede de preparation de tetrahydroimidazo (1,4) benzodiazepin -2- thiones antivirales
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
ES469020A1 (es) Procedimiento para la preparacion de nuevos 1-acil-2-hidroxi-1,3-diaminopropanos
DE2967356D1 (en) Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them
EP0104826A3 (en) Immunomodulator and method of use for immunomodulation
MXPA01004457A (es) Derivados pirimidina novedosos y procesos para la preparacion de los mismos.
HUP9901659A2 (hu) Flupirtin alkalmazása a hematopoetikus sejtrendszer károsodásával kapcsolatos megbetegedések megelőzésére és gyógyítására alkalmas gyógyszerkészítmény előállítására
RU94040865A (ru) Производные пептида и их терапевтически приемлемые соли, способ их получения, фармацевтическая и косметическая композиция с антивирусной активностью
EP0209843A3 (en) Benzylpiperazine compound, preparation thereof, pharmaceutical composition, and use
IE870577L (en) Topical amide preparation
ES473090A1 (es) Un procedimiento para la preparacion de l-(piro)glutamil-l- histidil-glicina
AU4831279A (en) New compounds
UA41326C2 (uk) Фармацевтична композиція для профілактики або лікування вірусних захворювань, засіб для профілактики або лікування вірусних захворювань

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19980302